Latest news
Altimmune, Inc. (ALT) options chain – Yahoo Finance - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 10:44:23 GMTAltimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026 - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTAltimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:00:00 GMTAltimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTAltimmune Shares Jump After Positive Phase 2 Alcohol Use Disorder Trial Results - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTAltimmune’s Pemvidutide Meets Phase II Endpoint in Alcohol Use Disorder Trial - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTAltimmune’s Investigational Therapy For Alcohol Use Disorder Meets Primary Endpoint – ALT Stock Jumps 10% - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTAltimmune's drug meets main goal of mid-stage study for alcohol use disorder - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT